Raw Liraglutide powder (204656-20-2) video
Raw Liraglutide powder (204656-20-2) Description
Liraglutide powder (204656-20-2) is a GLP-1 analog and a medication used to treat diabetes mellitus type 2 and obesity. in which lysine at position 34 has been replaced with arginine, and palmitic acid has been attached via glutamoyl spacer to lysine at position 26. No animal-derived raw materials or excipients are used in the production of Raw Liraglutide powder (204656-20-2). The drug product is a solution for subcutaneous injection containing 6.0 mg/ml of the drug substance presented in a pre-filled, multi-dose pen-injector. Unlike GLP-1, Raw Liraglutide powder has a pharmacokinetic and pharmacodynamic profile in human suitable for once daily administration.
Liraglutide powder is also a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing insulin release from the pancreas and decreases excessive glucagon release.
Raw Liraglutide powder (204656-20-2) Specifications
|Product Name||Liraglutide powder|
|Chemical Name||Glycine,L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];|
|Molecular Weight||3751.262 g/mol|
|Monoisotopic Mass||3748.946 g/mol|
|Melting Point||>182°C (dec.)|
|Biological Half-Life||approximately 13 hours.|
|Solubility||Soluble in DMSO|
|Storage Temperature||Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).|
|Application||used as a hypoglycemic agent and supplemental therapy in the treatment of Diabetes by patients who do not respond to Metformin, to treat diabetes mellitus type 2 and obesity.|